Get the Stockscreener App
3.69
3.07%
0.11
After Hours:
3.72
0.03
+0.81%
Ccc Intelligent Solutions Holdings Inc stock is traded at $3.69, with a volume of 2.45M.
It is up +3.07% in the last 24 hours and down -5.87% over the past month.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.
See More
Previous Close:
$3.58
Open:
$3.48
24h Volume:
2.45M
Relative Volume:
0.79
Market Cap:
$407.99M
Revenue:
$34.86M
Net Income/Loss:
$-103.80M
P/E Ratio:
-3.1155
EPS:
-1.1844
Net Cash Flow:
$-96.02M
1W Performance:
-9.11%
1M Performance:
-5.87%
6M Performance:
+65.47%
1Y Performance:
+69.27%
1-Day Range:
$3.44
$3.77
1-Week Range:
$3.44
$4.05
52-Week Range:
$1.6901
$5.17
Ccc Intelligent Solutions Holdings Inc Stock (CCCC) Company Profile
Name
Ccc Intelligent Solutions Holdings Inc
Sector
Industry
Phone
(617) 231-0700
Address
490 ARSENAL WAY, WATERTOWN
Compare CCCC vs PANW, SAP, SHOP, UBER, CRM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CCCC
Ccc Intelligent Solutions Holdings Inc
|
3.69 | 395.83M | 34.86M | -103.80M | -96.02M | -1.1844 |
PANW
Palo Alto Networks, Inc.
|
358.68 | 288.50B | 10.61B | 842.80M | 3.79B | 1.2157 |
SAP
Sap Se Adr
|
159.04 | 188.72B | 43.29B | 8.86B | 9.44B | 7.4066 |
SHOP
Shopify Inc
|
123.56 | 162.28B | 12.37B | 1.33B | 2.12B | 1.0172 |
UBER
Uber Technologies Inc
|
72.46 | 150.72B | 53.69B | 8.60B | 9.80B | 4.0128 |
CRM
Salesforce Inc
|
170.77 | 141.42B | 42.83B | 8.02B | 14.66B | 8.6388 |
Ccc Intelligent Solutions Holdings Inc Stock (CCCC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | TD Cowen | Buy |
| Sep-17-25 | Initiated | Barclays | Overweight |
| Sep-15-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Sep-04-25 | Initiated | Guggenheim | Buy |
| Dec-19-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-18-24 | Initiated | Stephens | Equal-Weight |
| Jan-29-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-13-23 | Upgrade | Stifel | Hold → Buy |
| Feb-24-23 | Upgrade | Credit Suisse | Underperform → Neutral |
| Feb-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-04-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-11-22 | Initiated | Morgan Stanley | Underweight |
| Apr-28-22 | Initiated | Credit Suisse | Underperform |
| Apr-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-10-22 | Initiated | JP Morgan | Overweight |
| Feb-11-22 | Resumed | BMO Capital Markets | Outperform |
| Feb-10-22 | Initiated | Wells Fargo | Equal Weight |
| Nov-23-21 | Initiated | BofA Securities | Buy |
| Oct-14-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-30-21 | Initiated | Stifel | Hold |
| Jun-04-21 | Initiated | H.C. Wainwright | Buy |
| Mar-31-21 | Initiated | BMO Capital Markets | Outperform |
| Oct-28-20 | Initiated | UBS | Buy |
| Oct-27-20 | Initiated | BMO Capital Markets | Outperform |
| Oct-27-20 | Initiated | Jefferies | Buy |
View All
Ccc Intelligent Solutions Holdings Inc Stock (CCCC) Latest News
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
Analysts Offer Insights on Technology Companies: Aehr Test Systems (AEHR) and CCC Intelligent Solutions Holdings (CCC) - The Globe and Mail
Principal Financial Group Inc. Buys 1,189,466 Shares of CCC Intelligent Solutions Holdings Inc. Common Stock $CCC - MarketBeat
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
CCC Intelligent Solutions Stock Rises Following Reports of Elliott Investment Management Stake - TIKR.com
Software Firm CCC Intelligent Solutions Exploring Sale: Reuters - Claims Journal
CCC Intelligent Solutions rises on report of firm exploring sale - MSN
C4 Therapeutics (NASDAQ: CCCC) CMO gains shares via RSU vesting, withholds some for taxes - Stock Titan
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Is CCC Intelligent Solutions Holdings Inc. (CCC) the Next Buyout Target? - Yahoo Finance
Elliott Management's Quiet Play: Why CCC Intelligent Solutions is Primed for a Private Equity Takeover - Kavout | AI
$5.91 | CCC Intelligent Solutions Holdings Inc. Common Stock (CCC) Stock Price Today - Binance
Activist investor Elliott builds a large stake in CCC: Bloomberg - Seeking Alpha
CCC Intelligent Solutions jumps on report of potential sale process (CCC) - MSN
Hedge fund Elliott builds stake in software firm CCC — Bloomberg - The Edge Malaysia
Hedge Fund Elliott Builds Stake in Software Firm CCC - Bloomberg.com
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
C4 Therapeutics (CCCC) upgraded to buy: What does it mean for the stock? - MSN
CCC Stock Grinds Higher As Traders Track Steady Uptrend - StocksToTrade
CCC Stock Grinds Higher As Tight Range Attracts Traders - StocksToTrade
CCC Intelligent Solutions Holdings Inc. Common Stock (NASDAQ:CCC) Shares Gap UpStill a Buy? - MarketBeat
CCC Intelligent Solutions Holdings Reportedly Weighs Sale of the Business - marketscreener.com
CCC Intelligent Solutions rises on report of firm exploring sale (NASDAQ:CCC) - Seeking Alpha
CCC Intelligent Solutions, Circle rise premarket; Silo Pharma, Fermi America fall - Yahoo Finance
CCC Intelligent Solutions Jumps on Report of Potential Sale Process (CCC) - Yahoo Finance
Why is CCC Intelligent Solutions stock surging 15% today? By Investing.com - Investing.com India
12 Information Technology Stocks Moving In Friday's Pre-Market Session - Sahm
CCC Intelligent Solutions Stock Rallies 13% Overnight: Here's What's Going On - Benzinga
Software provider CCC Intelligent Solutions weighs sale, Reuters reports By Investing.com - Investing.com South Africa
Software provider CCC Intelligent Solutions weighs sale, Reuters reports - Investing.com
CCC Intelligent Solutions Announces Date of Second Quarter 2026 Earnings Call - The Manila Times
CCC Intelligent Solutions schedules July 30 earnings call - Stock Titan
Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Is C4 Therapeutics (CCCC) stock outpacing its medical peers this year? - MSN
C4 Therapeutics (CCCC) Status Update Summary - Quartr
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
C4 Therapeutics, Inc. (CCCC) Is Up 2.65% in One Week: What You Should Know - Yahoo Finance
C4 Therapeutics (CCCC) Gains Over the Past Month, Can It Go Higher? - Yahoo Finance
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Director at C4 Therapeutics (CCCC) takes 3,341 shares as fees - Stock Titan
Director of C4 Therapeutics (NASDAQ: CCCC) receives 2,650-share stock award - Stock Titan
Ccc Intelligent Solutions Holdings Inc Stock (CCCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):